For people with type 2 diabetes, Ozempic and Mounjaro may increase the risk of damage to the eyes (diabetic retinopathy)
The significance of these GABA/glutamate trends are unknown but may reflect compensatory immunomodulation, diet, microbiota, infection or unknown exogenous factors
The Rise of Mobile IV Therapy Companies Despite the lack of insurance coverage, IV vitamin therapy has become more accessible than ever thanks to the rise of mobile IV therapy companies
[Effect of exendin-4 on lipid deposition in skeletal muscle of diet-induced obese mice and its underlying mechanism]
Clinicians can review broader guidance on GLP-1 receptor agonists through the American Diabetes Association at diabetes.org
Despite not being officially sanctioned for obesity treatment, demand for Ozempic has skyrocketed, primarily fueled by those seeking its weight loss benefits